Oppenheimer Downgrades Regeneron Pharma (REGN) to Perform

February 13, 2014 7:06 AM

Oppenheimer downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform to Perform with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found